BioTech Medics Inc. Negotiating Multiple North Dallas Texas Locations
May 25 2006 - 9:00AM
PR Newswire (US)
DALLAS, May 25 /PRNewswire-FirstCall/ -- BioTech Medics, Inc., (OTC
Pink Sheets: BTMD) announced today that they have made a
presentation to doctors and staff at the Muenster Memorial Hospital
in Texas with the intention to open a BioTech Medics Pain
Management and Wellness Center Outpatient Clinic. "This will
provide a convenient location for patients in North Texas and the
Southern Oklahoma area to be treated. With the high cost of
gasoline, this will save patients money from having to travel about
200 miles round trip to Dallas for treatment", said Keith Houser,
CEO. "We are also in negotiations to open a BioTech Medics Pain
Management & Wellness Center in Rockwall, Texas. Rockwall is
one of the fastest growing communities in Texas," said Mr. Houser.
"This will provide a more convenient center for those who live in
East Texas." BioTech Medics is a distributor for the FDA cleared
NeuroLase Therapeutic Medical Laser. The NeuroLase is one of the
most powerful Class 3B therapeutic lasers in the USA which is for
the temporary reduction or elimination of muscular, skeletal and
arthritic pain without drugs or surgery. Medical practitioners
seeking to provide drug-free pain management for their patients are
encouraged to contact BioTech Medics. For more information contact:
Keith Houser, CEO Phone 972-274-5533 On the web at:
http://www.biotechmedics.com/ Safe Harbor for Forward-Looking
Statements. This press contains forward-looking statements within
the meaning of The Private Securities Litigation Reform Act of 1995
(the "Act"). In Particular, when used in the preceding discussion,
the words "plan," "confident that," "believe," "scheduled,"
"expect," or "intend to," and similar conditional expressions are
intended to identify forward-looking statements within the meaning
of the Act and are subject to the safe harbor created by the Act.
Such statements are subject to certain risks and uncertainties and
actual results could differ materially from those expressed in any
of the forward- looking statements. Such risks and uncertainties
include, but are not limited to, the ability of the company to
complete financing, market conditions, the general acceptance of
the Company's products and technologies, timing, and other risks.
DATASOURCE: BioTech Medics, Inc. CONTACT: Keith Houser, CEO of
BioTech Medics, Inc., +1-972-274-5533 Web site:
http://www.biotechmedics.com/
Copyright